Evidence map›Paper›PMID 42640407›Full record

ArticleInfection2026

Characteristics of late HIV diagnosis in Germany in 2019 and 2020 - A regional analysis.

Carlotta Helbig, Susanne Mohr, Mathias W Pletz, Juliane Ankert, Jens Forthmann, Markus Bickel, Christoph Stephan, Olaf Degen, Sebastian Noe, Hans Wesselmann and 20 more

Abstract read
PubMed Publisher
In one paragraph

Article in Infection, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

30 authors.

Carlotta HelbigInstitute of Infectious Diseases and Infection Control, Jena University Hospital, Friedrich-Schiller-University, Jena, Germany.ORCID http://orcid.org/0009-0004-9274-5911
Susanne MohrDepartment of Psychosomatic Medicine and Psychotherapy, Jena University Hospital, Friedrich-Schiller-University, Jena, Germany.
Mathias W PletzInstitute of Infectious Diseases and Infection Control, Jena University Hospital, Friedrich-Schiller-University, Jena, Germany.
Juliane AnkertInstitute of Infectious Diseases and Infection Control, Jena University Hospital, Friedrich-Schiller-University, Jena, Germany.
Jens ForthmannICH Study Center Hamburg, Hamburg, Germany.
Markus BickelInfektiologikum Frankfurt, Frankfurt Am Main, Germany.
Christoph StephanDepartment of Internal Medicine, Infectious Diseases, University Hospital Frankfurt, Frankfurt Am Main, Germany.
Olaf DegenClinic for Infectious Diseases, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Sebastian NoeMVZ München Am Goetheplatz, Munich, Germany.
Hans WesselmannDepartment of Infectious and Respiratory Medicine, Charité Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität Zu Berlin, Berlin, Germany.
Daniela TominskiDepartment of Infectious Diseases, Vivantes Auguste-Viktoria-Klinikum, Berlin, Germany.
Stefanie HolmPraxis Georgstrasse, Hanover, Germany.
Christoph SpinnerClinical Department of Internal Medicine II, TUM School of Medicine and Health, TUM University Hospital, Munich, Germany.
Neel PetersenSecond Medical Department, University Hospital Schleswig-Holstein, Kiel, Germany.
Christoph BoeseckeDepartment of Medicine I, University Hospital Bonn, Bonn, Germany.
Axel BaumgartenCenter for Infectiology Berlin-Prenzlauer Berg, Berlin, Germany.
Wolfgang SchmidtMVZ Infektiologie Ärzteforum Seestrasse, Berlin, Germany.
Sven BeckerDiabeteszentrum Erfurt, Erfurt, Germany.
Hartmut StockerDepartment of Infectious Diseases, St. Joseph Hospital, Berlin-Tempelhof, Berlin, Germany.
Christoph LübbertDivision of Infectious Diseases and Tropical Medicine, Department of Medicine I, Leipzig University Medical Center, Leipzig, Germany.
Thomas HeuchelMedcenter Chemnitz, Chemnitz, Germany.
Christoph WyenPraxis Am Ebertplatz, Cologne, Germany.
Wilfried ObstDepartment of Gastroenterology, Hepatology and Infectious Diseases, Otto-Von-Guericke University Magdeburg, Magdeburg, Germany.
Ines RuckPraxis Dr. Ruck, Leipzig, Germany.
Steve RößlerArztpraxis Rößler, Zwickau, Germany.
Heribert KnechtenLaboratory Dr. Knechten, Medical Center for HIV and Hepatitis, Aachen, Germany.
Michael WaizmannMedcenter Leipzig, Leipzig, Germany.
Thomas SeidelMedcenter Weimar, Weimar, Germany.
Benjamin T SchleenvoigtInstitute of Infectious Diseases and Infection Control, Jena University Hospital, Friedrich-Schiller-University, Jena, Germany. benjamin.schleenvoigt@med.uni-jena.de.ORCID http://orcid.org/0000-0003-4678-2469
HIV-regional study group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeA large proportion of HIV diagnoses are made at an advanced stage of infection and different patient characteristics have been associated with late diagnosis of HIV. This study aims to assess the prevalence of late HIV diagnosis, to characterize individuals diagnosed at a late stage of infection and to evaluate regional differences in Germany.

methodsThis retrospective, cross-sectional analysis included 1,169 individuals newly diagnosed with HIV in 2019 and 2020. Data on patient demographics, information on the HIV diagnosis and laboratory parameters were collected. Late diagnosis and advanced HIV disease were defined according to established consensus criteria. Regional comparison was made between eastern and western Germany.

resultsIn our cohort, 82.6% of the individuals were male and 16.9% female, with a median age of 39 years (IQR: 31-50). The prevalence of late diagnosis was 61.6% and advanced HIV disease, as a subgroup of late diagnosis, was present in 41.7%. Individuals with late diagnosis were significantly older than those diagnosed at an earlier stage (p < 0.001). Patients in eastern Germany were diagnosed at more advanced stages of infection with significantly higher rates of late diagnosis (p < 0.01), advanced HIV disease (p < 0.001), and AIDS-defining conditions (p < 0.001), as well as significantly lower CD4 cell counts (p < 0.001).

conclusionOur data demonstrate that a high proportion of HIV diagnoses in Germany are made at a late stage of infection. Late diagnosis was more frequent in older individuals and in those living in eastern Germany. These findings highlight the need for strengthened HIV testing strategies, particularly in underserved populations and regions.

Indexed as

AIDSCD4HIVLate diagnosisPLWH

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.